109311 ⎘
Active agents used in cell culture processes, e.g. differentation; Growth factors Heregulin, neu differentiation factor
METHODS OF PRODUCING A TUMOR AVATAR
#2NEURONAL REGENERATION PROMOTING CELLS (NRPCs) AND TREATING DAMAGED NERVE CELLS
#3MEDIUM AND METHOD FOR PREPARATION OF SALIVARY GLAND ORGANOID
#4Proteolytic Enzymes for Cell Culture Media
#5CELL ENCAPSULATION DEVICE COMPRISING A PANCREATIC PROGENITOR CELL POPULATION
#6NEURONAL REGENERATION PROMOTING CELLS (NRPCs) AND TREATING DAMAGED NERVE CELLS
#7ENDOCRINE CELLS THAT EXPRESS CHROMOGRANIN A
#8MEDIA AND METHODS FOR GROWING MAMMARY ORGANOIDS
#9CRYOPRESERVED ENDOCRINE CELLS THAT EXPRESS CHROMOGRANIN A
#10Therapeutic Human Mast Cells, Compositions, and Methods of Treating a Tumor Comprising Administering Autologous Human Mast Cells from Adipose Tissue
#11METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS
#12Scalable primate pluripotent stem cell aggregate suspension culture
#13Cell encapsulation device comprising a pancreatic progenitor cell population
#14Cryopreserved endocrine cells that express chromogranin A
#15Production of fully functional mature beta cells from human pancreatic progenitors
#16Scalable primate pluripotent stem cell aggregate suspension culture
#17CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS
#18Methods for producing hormone secreting cells in a subject
#19Cell compositions derived from dedifferentiated reprogrammed cells
#20Populations of mesenchymal stem cells that secrete neurotrophic factors
#21Cell compositions derived from dedifferentiated reprogrammed cells
#22Compositions for mesoderm derived ISL1+ multipotent cells (IMPs), epicardial progenitor cells (EPCs) and multipotent C56C cells (C56Cs) and methods of producing and using same
#23Compositions and Methods Useful for Culturing Differentiable Cells
#24Methods of generating mesenchymal stem cells which secrete neurotrophic factors
#25Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
#26MicroRNAs for the generation of astrocytes
#27In vitro differentiation of pluripotent stem cells to pancreatic endoderm cells (PEC) and endocrine cells
#28Small molecules supporting pluripotent cell growth and methods thereof
#29Cell compositions derived from dedifferentiated reprogrammed cells
#30Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
#31Compositions and methods useful for culturing differentiable cells
#32Stem cell aggregate suspension compositions and methods of differentiation thereof
#33Small molecules supporting pluripotent cell growth and methods thereof
#34COMPOSITIONS FOR MESODERM DERIVED ISL1+ MULTIPOTENT CELLS (IMPs), EPICARDIAL PROGENITOR CELLS (EPCs) AND MULTIPOTENT CD56C CELLS (C56Cs) AND METHODS OF PRODUCING AND USING SAME
#35IN SITU IMMUNIZATION
#36Human Cancer Stem Cell Culture Compositions Comprising ErbB2 Variants and Methods of Use
#37Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (MMC)
#38Stem cell aggregate suspension compositions and methods of differentiation thereof
#39COMPOSITION FOR TREATING DAMAGE OF CENTRAL OR PERIPHERAL NERVE SYSTEM
#40Multipotent stem cells from peripheral tissues and uses thereof
#41Multipotent stem cells from peripheral tissues and uses thereof
#42Compositions and methods useful for culturing differentiable cells
#43Method for inducing differentiation to skeletal muscle cells
#44Methods for culturing pluripotent stem cells in suspension using ERBB3 ligands
#45Human cancer stem cell culture compositions comprising Erbb2 variants and methods of use thereof
#46Human schwannoma cell line
#47Methods of Making and Using Skin-Derived Stem Cells
#48Multipotent stem cells from peripheral tissues and uses thereof